Neuravastatin (Neuraclair)
Product detail for Neuravastatin, INN: neuravastatin. Therapeutic area: Neurology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-007
INN
neuravastatin
Therapeutic Area
Neurology
Status
Approved
Owner
Marcus Webb
Created
2022-05-06
Last Updated
2023-02-26
Markets
9
Presentations
| Form | Strength | Route |
|---|---|---|
| Powder for injection | 25 mg | Intramuscular |
| Hard capsule | 10 mg/mL | Transdermal |
| Inhalation powder | 400 mg | Intravenous |
| Inhalation powder | 1 mg/mL | Intravitreal |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-017 | Thymosilib | thymosilib | 94484-27-2 | biologic | Active |
| SUB-025 | Tisagenlecleux beta | tisagenlecleux beta | 12667-73-1 | small-molecule | Active |
Applications (4)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| TGA-2023-0007 | Australia | Label Update | Submitted | Lieselotte van der Berg | 2022-11-07 |
| SFDA-2023-0037 | Australia | Lifecycle Extension | Completed | James O'Brien | 2022-07-14 |
| TGA-2023-0067 | Australia | NDA | Active | Carlos Mendez | 2022-10-21 |
| SFDA-2023-0097 | Australia | sNDA | Completed | Dmitri Volkov | 2024-04-26 |
Markets (9)